A case that the U.S. Supreme Court has agreed to hear could dramatically expand the amount of damages potentially available in patent cases, as the court weighs whether patent owners should be able to recover profits lost outside the U.S. due to infringement.
Delivering a blow to Samsung, a Virginia judge has rejected the Korean electronics maker’s request that Rambus Inc. pick up the tab for its attorneys' fees, despite the chip maker's “unclean hands” in the long-simmering semiconductor patent case.
More than one third of small high-tech companies surveyed in 2005 failed to receive all revenue due from their licensing agreements during the past year, according to a recent report.
Faced with the choice of accepting a $133.6 million jury award—an amount the judge slashed by $174 million—or risking a new trial, Rambus Inc. took the safer route.
A U.S. Appeals Court upheld a lower court decision Wednesday that will allow Sony Ericsson to continue marketing two different cell phones.
Federal prosecutors are taking aim at a deal involving the hotly-contested heart drug Plavix, launching a criminal investigation of a proposed settlement between Bristol-Myers Squibb Co., Sanofi-Aventis and Apotex Inc.
In a bid to become a legal download service, Internet file-sharing network Kazaa said this week it will shell out more than $100 million in a global out-of-court settlement with a slew of record companies, bringing to an end to its long-running feud with the music and entertainment industry.
A pharmaceutical unit of health care giant Johnson & Johnson has filed a patent infringement lawsuit against U.S. rival Wyeth over the drug-delivery system used in Wyeth’s popular antidepressant Effexor XR.
When patent owners raise prices and make combination products more expensive in the process, they cannot be sued for monopoly leveraging under U.S. antitrust laws, according to a ruling Wednesday by the U.S. Court of Appeals for the Seventh Circuit.
Japanese electronics giant Matsushita Electric Industrial Co. Ltd. has hit a Taiwanese rival with a patent infringement suit, alleging the optical disc maker’s DVD discs violated its patents.
Under investigation by the U.S. Department of Justice for alleged price-fixing, Stryker Corp. received a piece of good news this week when it won a summary judgment decision dismissing a patent infringement lawsuit brought against it by Luma Corp.
With South Korea and the United States still tussling over trade agreements for pharmaceuticals, South Korea intends to forge ahead with drug-pricing legislation that could have a substantial material impact on U.S. drug sales in Korea.
Exhibits and testimony offered behind closed doors may soon be made public in the ongoing antitrust litigation between semiconductor maker Rambus and several other chip makers.
Semiconductor company Mosaid Technologies Inc. shot off a countersuit against rival Micron Technology Inc. Tuesday just hours after Micron announced its own lawsuit seeking the invalidation of 14 Mosaid patents.
A long-running biotech patent infringement lawsuit between life science companies Invitrogen Corp. and Stratagene Corp. over a patent involving a process of creating competent E. coli cells was brought to a close by a Texas jury’s ruling on Tuesday.
Tyco International Ltd.’s health care unit has jabbed longtime competitor Applied Medical Resources Corp. with a patent infringement suit, alleging it violated Tyco’s patents for medical devices used in minimally invasive surgery.
Entegris Inc. and Miraial Co. Ltd. have struck a deal ending a yearlong patent infringement suit that centered on technology used to protect the fragile wafers used to manufacture microchips.
Not long ago, it was nearly unheard of for universities or hospitals to litigate patent cases. Cedars-Sinai Medical Center in Los Angeles did not even file a patent application in its first 80 years of existence. But times have changed.
Legislation creating so-called “Rocket Dockets” to speed up patent cases and reduce reversal rates on appeal eased through a Congressional markup Thursday after concerns about possible forum shopping were addressed.
Owners of trademarks and related publicity rights are chalking up another victory after a federal appeals court ruled recently that licensees couldn’t assign those rights to third parties without the licensor’s express permission.
A bottleneck at the USPTO is stunting growth in IP for nanotechnology, creating an air of uncertainty about what’s expected to be a wave of patent litigation in the industry.